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ABSTRACT
Background: Acute diarrhea is a common problem in developing country such as Indonesia with quite high 
PRUELGLW\DQGPRUWDOLW\UDWH,WZDVUHYHDOHGWKDWWKHOHYHORI]LQFGH¿FLHQF\LQDGXOWDFXWHGLDUUKHDSDWLHQWV
LQVHYHUDOKRVSLWDOVLQ-DNDUWDZDV$OWKRXJK]LQFKDVEHHQSURYHQWREHEHQH¿FLDOLQWKHWUHDWPHQWRI
acute diarrhea in pediatric patients, the effect of zinc supplementation is not fully understood. The objective of 
this study was to discover the effectiveness of zinc supplementation as an adjuvant therapy in acute diarrhea 
for adult patients.
Method: A double blind randomized controlled trial was done to discover the effect of zinc supplementation 
to the duration, signs and symptoms on acute diarrhea in hospitalized adults patients in Pertamina Central 
Hospital, Jakarta from January to December 2013. The data was analyzed using Chi-square test to compare the 
duration of diarrhea and general linear model (GLM) to assess changes of the symptoms accompanying diarrhea. 
Results: Data analysis from 84 patients, 30 males (19 zinc, 11 placebo) and 54 females (23 zinc, 31 placebo) 
ZLWKS VKRZHGWKDW]LQFVXSSOHPHQWDWLRQVLJQL¿FDQWO\UHGXFHGWKHGXUDWLRQRIDFXWHGLDUUKHDS 
and nausea (p = 0.032). In addition there is a tendency of improvement in several acute diarrhea associated 
symptoms.
Conclusion:=LQFVXSSOHPHQWDWLRQVLJQL¿FDQWO\UHGXFHVWKHGXUDWLRQRIGLDUUKHDQDXVHDDVZHOODVLPSURYLQJ
some symptoms accompanying acute diarrhea.
Keywords: zinc supplementation, acute diarrhea, adult patient
ABSTRAK
Latar belakang: Diare akut adalah masalah umum di negara berkembang seperti Indonesia dengan angka 
morbiditas dan mortalitas yang cukup tinggi. Pada beberapa rumah sakit di Jakarta ditemukan bahwa pasien 
GLDUH DNXW GHZDVDPHQJDODPL GH¿VLHQVL NDGDU VHQJ VHEHVDU 3HPEHULDQ VHQJ WHUEXNWL EHUPDQIDDW
untuk pengobatan diare akut pada anak. Namun, efek suplementasi seng pada pasien dewasa belum diketahui 
sepenuhnya. Tujuan penelitian ini adalah untuk mengetahui dampak suplementasi seng sebagai terapi alternatif/
adjuvant untuk pengobatan diare akut pada pasien dewasa.
Metode: Double blind randomized controlled trial diterapkan pada penelitian ini untuk mengetahui efek 
suplementasi seng terhadap durasi dan gejala gastrointestinal pada pasien diare akut rawat inap di Rumah 
Sakit Pusat Pertamina, Jakarta selama periode Januari hingga Desember 2013. Analisis data dilakukan dengan 
menggunakan uji Chi-square untuk perbandingan durasi diare dan uji model linear umum untuk menilai tren 
perubahan gejala penyerta diare.
Hasil: Analisis data dari 84 pasien yang dikelola, yaitu 30 pasien laki-laki (seng 19, plasebo 11) dan 54 pasien 
perempuan (seng 23, plasebo 31) dengan p = 0.111 memperlihatkan pemberian suplementasi seng bermakna 
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mengurangi durasi diare akut (p = 0.027) dan bermakna mengurangi gejala mual (p = 0.032). Selain itu ada 
tren perbaikan pada sebagian gejala penyerta diare akut.
Simpulan: Pemberian suplementasi seng bermakna mengurangi durasi diare dan gejala mual, serta perbaikan 
pada sebagian gejala gastrointestinal.
Kata kunci: suplementasi seng, diare akut, pasien dewasa
INTRODUCTION
Acute diarrhea is a common problem in developing 
countries, such as Indonesia. The morbidity and 
mortality rate of diarrhea in Indonesia are relatively 
high.1-2 According to studies taken in Indonesia, 
GLDUUKHDLVWKHth leading cause of death.2 Diarrhea 
is frequently accompanied with gastrointestinal 
symptoms such as nausea, vomiting, abdominal pain, 
fever, bloody stool, and rectal tenesmus. In most of 
cases, acute diarrhea is a self-limiting disease, but 
in some cases, it can be severe and life threatening. 
Therefore, an effective and precise therapy is needed 
to reduce the morbidity and mortality rate. 
In developing countries, diarrhea is often related 
ZLWK]LQFGH¿FLHQF\,QDVWXG\FDUULHGRXWLQ'LYLVLRQ
of Gastroenterology, Cipto Mangunkusumo Hospital, 
-DNDUWDLQSURSRUWLRQRI]LQFGH¿FLHQF\LQDGXOW
ZLWK DFXWH GLDUUKHDZDV 4 This founding is 
FRQVLVWHQWZLWK]LQFGH¿FLHQF\LQFKLOGUHQZLWKDFXWH
diarrhea.5 Recent meta-analysis showed that zinc 
supplementation reduce the incidence of diarrhea 
WR  SDUWLFXODUO\ LQ FKLOGUHQ EHORZ \HDU ROG6 
Although the mechanism of zinc in diarrhea is not fully 
XQGHUVWRRG]LQFVKRZHGJUHDWEHQH¿WLQVWUHQJWKHQLQJ
immunity against infection and reducing the duration 
and risk of diarrhea.4 It is suggested that zinc increases 
LQWHVWLQDOÀXLGDEVRUSWLRQDLGVRUJDQLVPHOLPLQDWLRQ
and enhances mucosal integrity and regeneration as 
well as interrelated with the immune system.6
7KHUHLVDVKRUWDJHRIGDWDDERXW]LQFGH¿FLHQF\LQ
adult population with diarrhea. National data about zinc 
GH¿FLHQF\LQFOXGLQJVXEFOLQLFDOGH¿FLHQF\LQDGXOWVLV
scarce. Hence, this study aimed the symptoms related 
ZLWK]LQFGH¿FLHQF\ LQDGXOWSDWLHQWVZLWKGLDUUKHD
as well as the effects of zinc supplementation towards 
recovery and relieving diarrhea associated symptoms. 
METHOD
This is a double blind randomized control trial 
study. This study, which investigated the effects of 
zinc supplementation in adult acute diarrhea patients 
compared with placebo, was a continuation of the study 
that evaluate zinc level in adult diarrhea patients in 
Jakarta.4 This study was conducted in Pertamina Central 
+RVSLWDOIURP-DQXDU\XQWLO'HFHPEHU
The inclusive criteria that were included were age 
EHWZHHQWR\HDUVROGDQGDFXWHGLDUUKHDZLWKRXW
complication. Meanwhile the exclusive criteria were 
SDWLHQWVZLWKLUULWDEOHERZHOV\QGURPHLQÀDPPDWRU\
bowel disease and chronic diarrhea, colon disease 
VXFKDVLQÀDPPDWRU\ERZHOGXHWRUDGLDWLRQERZHO
adhesion, colon cancer, gastrointestinal operation 
ZLWKLQ PRQWKV SDWLHQWVZKR UHFHLYHG DQWLELRWLFV
kidney failure, metabolic acidosis, hypovolemic 
VKRFNLPPXQRVXSSUHVVDQWDQGRULPPXQRPRGXODWRU
recipients, not cooperative, every disease that could 
endanger patient, known or suggestive allergic to the 
research or related products, for women in childbearing 
DJH FXUUHQWO\ SUHJQDQW EUHDVWIHHG RU LQWHQW WR JHW
pregnant, and patients who underwent chemotherapy 
DQGRUUDGLRWKHUDS\
Sample recruitment was carried out consecutively 
for all patients who were admitted in Pertamina 
Central Hospital. Patients who met the inclusive and 
exclusive criteria were randomized into zinc group and 
placebo group. The zinc group received 20 mg zinc 
sulphatetwice a day for 7 days. Patients were given a 
diary to monitor their conditions and symptoms.
7KHSDWLHQWVIXO¿OOHGWKHFULWHULDXQGHUZHQWVHYHUDO
steps that included history taking, and physical 
examination. The data collected were age, sex, body 
mass index (BMI), the severity of acute diarrhea, 
length of diarrhea, and other symptoms such as fever, 
abdominal pain, nausea, vomiting, tenesmus, bloody 
stool, thirst, stool consistency, mucus in stool, less 
urination, disturbed daily activities, and headache.
SPSS for Windows version 17 was used to data 
analysis. The data was presented using texts, tables or 
graphics; Chi-square was used to analyze the duration 
of diarrhea, and general linear model (GLM) was used 
to analyze the diarrhea associated symptoms.
This study was approved and received ethical 
clearance from the Medical Committee of Ethics, 
Faculty of Medicine, University of Indonesia. Every 
GDWDFROOHFWHGIURPPHGLFDOUHFRUGVZHUHFODVVL¿HG
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RESULTS
$WRWDORISDWLHQWVZLWKDFXWHGLDUUKHDWKDWIXO¿OO
the inclusion and exclusion criteria, were enrolled 
LQ WKLV VWXG\ZLWK D SURSRUWLRQ RI PDOH DQG 
IHPDOHV7KHUHZHUH QHLWKHU VLJQL¿FDQW GLIIHUHQFH
of the subjects’ characteristics nor the diarrhea types 
between two groups. The proportion of symptoms 
EHIRUH WKH WUHDWPHQWZDVQRW VLJQL¿FDQWO\ GLIIHUHQW
H[FHSWIRUWKHIHYHUS 
Table 1. Patients characteristics and the type of diarrhea
Variable
Group
n (%)
Placebo Zinc
Sex
Male
Female
11 (26.2)
31 (73.8)
19 (45.2)
23 (54.8)
Age (years)
< 20 
20-30 
31-40 
41-50 
51-60 
1 (50.0)
11 (52.4)
17 (58.6)
6 (42.9)
8 (44.4)
1 (50.0)
10 (47.6)
12 (41.4)
8 (57.1)
10 (55.6)
Diarrhea type
Infectious diarrhea
Non-infectious diarrhea
10 (23.8)
32 (76.2)
18 (42.9)
18 (42.9)
Etiology of infection
Virus
Bacteria
Fungus
Parasite
5 (11.9)
0 (0.0)
3 (7.1)
0 (0.0)
4 (9.5)
1 (2.4)
8 (19.0)
1 (2.4)
Non-infectious causes
1RWVSHFL¿F
Food
30 (71.4)
4 (9.5)
27 (64.3)
1(2.4)
Stool color
Brown
Green
Yellow
White
6 (14.3)
3 (7.1)
32 (76.2)
1 (2.4)
9 (21.4)
2 (4.8)
31 (73.8)
0 (0.0)
Blood in stool
None
Present
42 (50.6)
0 (0.0)
41 (49.4)
1 (100.0)
Table 2. Proportions of diarrhea associated symptoms before 
the treatment
Variable
Group
n (%)
Placebo Zinc
Frequency of bowel movements
3-5
6-10
> 10
11 (64.7)
11 (50.0)
20 (44.4)
6 (35.3)
11 (50.0)
25 (55.6)
Stool consistency
Liquid
Watery (½ liquid, ½ solid)
32 (58.2)
10 (34.5) 
23 (41.8)
19 (65.5)
Mucus 
Mone
Mild
Average
38 (51.4)
2 (25.0)
2 (100.0)
36 (48.6)
6 (75.0)
0 (0.0)
Tenesmus
None
Present
40 (49.4)
2 (66.7)
41 (50.6)
1 (33.33)
Abdominal pain
None
Mild
Average
Severe
7 (63.6)
14 (53.8)
21 (44.7)
0 (0.0)
4 (36.4)
12 (46.2)
26 (55.3)
0 (0.0)
Nausea
None
Mild
Average
Severe
2 (40.0)
16 (50.0)
23 (53.5)
1 (25.0)
3 (60.0)
16 (50.0)
20 (46.5)
3 (75.0)
Vomiting
None
Mild
Average
Severe
17 (53.1)
14 (46.7)
11 (50.0)
0 (0.0)
15 (46.9)
16 (53.3)
11 (50.0)
0 (0.0)
Flatulence
None
Mild
Average
Severe
3 (30.0)
21 (51.2)
18 (54.5)
0 (0.0)
7 (70.0)
20 (48.8)
15 (45.5)
0 (0.0)
Fever
Present 24 (64.9) 29 (61.7)
None 18 (38.3) 13 (35.1)
Headache 
None
Mild
Average
Severe
18 (52.9)
23 (51.1)
1 (20.0)
0 (0.0)
16 (47.1)
22 (48.90
4 (80.0)
0 (0.0)
Less urination
Present
None
39 (51.3)
3 (37.5)
37 (48.7)
5 (62.5)
Thirsty 
Present
None
29 (53.7)
13 (43.3)
25 (46.3)
17 (56.7)
Disturbing daily activities
None
Mild
Average
Severe
4 (100.0)
22 (52.4)
16 (42.1)
0 (0.0)
0 (0.0)
20 (47.6)
22 (57.9)
0 (0.0)
7KURXJKWKHGDWDFROOHFWHGIURPSDWLHQWVGXULQJ
GD\VRIWUHDWPHQWWKHUHZDVDVLJQL¿FDQWGLIIHUHQFHRI
diarrhea duration reduction between the two groups (p 
 5HJDUGLQJWKHDQDO\VLVRIGLDUUKHDDVVRFLDWHG
V\PSWRPV WKHUHZDV RQO\ VLJQL¿FDQW GLIIHUHQFH LQ
QDXVHD S +RZHYHU]LQF VXSSOHPHQWDWLRQ
showed trends of improvement in some diarrhea 
associated symptoms, consisting of abdominal pain, 
frequency of bowel movement, stool consistency, 
YRPLWLQJ ÀDWXOHQFH DQG GLVWXUEHG GDLO\ DFWLYLWLHV
Meanwhile, there was no difference in thirst, less 
urination, and fever parameters in both groups before 
and after the study.
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy86
Deskian Kostermans, Marcellus Simadibrata, Irsan Hasan, Laras Budiyani
Figure 1. The comparison of diarrhea duration between zinc 
and placebo group (p= 0.027)
supplementation reduce the severity of diarrhea in 
children in India.10 Zinc was found to lower the severity 
and incidence of persistent diarrhea in adults with 
HIV-1 infection.11 Meta-analysis reported by Galvao 
et all also concluded that zinc supplementation gave a 
VLJQL¿FDQWHIIHFWLQUHGXFLQJWKHGXUDWLRQRIGLDUUKHD12 
A double blind randomized controlled trial using 20 
mg zinc or placebo daily showed a decrease of diarrhea 
SUHYDOHQFHDQGLQFLGHQFHE\S DQG
S UHVSHFWLYHO\
This double blind randomized controlled trial 
H[SHULPHQWDOVWXG\ZDVGRQHZLWKVDPSOHVWUHDWHG
either as zinc group or placebo group. However, the 
limitation in this study was that most of the patients 
were discharged from hospital on the third day of 
admission. Therefore, the data were collected using 
phone calls that were not enough detail and laboratory 
analysis was not possible because many patients did 
not control after 1 week. Furthermore, the data was 
gathered from one hospital that only included patients 
from moderate to higher social status. 
CONCLUSION
From this study, we can conclude that zinc 
supplementation could enhance the improvement 
of acute diarrhea, reduce nausea, and have trends in 
improving several diarrhea associated symptoms, such 
as abdominal pain, frequency of bowel movements, 
VWRROFRQVLVWHQF\YRPLWLQJÀDWXOHQFHDQGGLVWXUEHG
daily activities. Because of that, zinc supplementation 
can be considered to be an additional therapy in adult 
acute diarrhea patients. Furthermore, another study 
with better methodology which consists of every social 
strata should be carried out following this study.
Table 3. The comparison of diarrhea associated symptoms between zinc and placebo group
Variable Group
Day
p
1 2 3 4 5 6 7
Abdominal pain Placebo 1.6 (0.09) 1.31 (0.09) 1.11 (0.06) 1.00 (0.03) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
0.194
Zinc 1.71 (0.09) 1.43 (0.09) 1.17 (0.06) 1.09 (0.03) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
Frequency of bowel 
movement
Placebo 3.12 (0.15) 2.64 (0.12) 2.21 (0.13) 2.05 (0.7) 1.98 (0.06) 1.98 (0.05) 1.98 (0.05)
0.276
Zinc 3.43 (0.15) 2.93 (0.12) 2.33 (0.13) 2.09 (0.79) 2.12 (0.07) 1.95 (0.05) 1.95 (0.05)
Stool consistency Placebo 1.76 (0.08) 1.93 (0.06) 1.93 (0.15) 2.43 (0.14) 2.45 (0.14) 2.76 (0.12) 2.76 (0.12)
0.833
Zinc 1.76 (0.07) 2.00 (0.66) 2.14 (0.15) 2.26 (0.14) 2.5 (0.13) 2.78 (0.12) 2.78 (0.12)
Mucus present Placebo 1.048 (0.04) 1.024 (0.02) 1.00 (0.017) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
0.393
Zinc 1.95 (0.04) 1.024 (0.02) 1.02 (0.017) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
Nausea Placebo 1.64 (0.11) 1.40 (0.08) 1.31 (0.06) 1.09 (0.05) 1.05 (0.04) 1.00 (0.0) 1.00 (0.0)
0.032
Zinc 1.88 (0.11) 1.50 (0.08) 1.20 (0.06) 1.20 (0.05) 1.11 (0.04) 1.00 (0.0) 1.00 (0.0)
Vomiting Placebo 1.476 (0.10) 1.20 (0.06) 1.14 (0.045) 1.048 (0.03) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
0.570
Zinc 1.48 (0.10) 1.21 (0.06) 1.05 (0.045) 1.024 (0.03) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
Flatulence Placebo 1.50 (0.10) 1.24 (0.07) 1.12 (0.06) 1.00 (0.02) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
0.538
Zinc 1.60 (0.10) 1.31 (0.07) 1.21 (0.05) 1.05 (0.24) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
Disturbed daily 
activities
Placebo 1.67 (0.11) 1.29 (0.07) 1.09 (0.05) 1.00 (0.024) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0) 0.148
Zinc 1.93 (0.11) 1.54 (0.07) 1.09 (0.05) 1.05 (0.02) 1.00 (0.0) 1.00 (0.0) 1.00 (0.0)
DISCUSSION
This study focused on the effect of zinc supplemen-
tation to adult patient with acute diarrhea. Zinc is 
one of essential micronutrients needed for the body 
processes.7 =LQF LV NQRZQ IRU LWV DQWLLQÀDPPDWRU\
and antioxidant effect as well as the role in immunity. 
Zinc effect towards acute diarrhea is due to its function 
in cellular works in increasing water and electrolyte 
intestinal absorption, enhancing intestinal epithelial 
regeneration, and improving brush border enzyme in 
the enterocyte. Zinc also has a role in immunity. Zinc 
GH¿FLHQF\LVHKHDOWKSUREOHPLQGHYHORSLQJFRXQWULHV
=LQFVXSSOHPHQWDWLRQVLJQL¿FDQWO\UHGXFHVWKHUDWHRI
diarrhea.7.9
After conducting the experimental study with 
adjustment to age, comorbid, and history of medical 
treatment using the bivariate analysis, we found that the 
]LQFVXSSOHPHQWDWLRQVLJQL¿FDQWO\UHGXFHWKHGLDUUKHD
GXUDWLRQS %HVLGHVWKDWLWDOVRVLJQL¿FDQWO\
LPSURYHQDXVHDLQDFXWHGLDUUKHDOSDWLHQWS 
This study is concordance with previous 
study conducted in India which showed that zinc 
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